Patients with GLP-1 receptor agonists or dual GIP and GLP-1 receptor agonist use during the 12-month baseline period were excluded, as were those with diabetes, prior metabolic bariatric procedures, or conditions associated with unintentional weight change
The 12mg dose produced the headline results: 24.2% mean body weight reduction at 48 weeks
[PMC free article] [PubMed] [Google Scholar] Aliev G., Liu J., Shenk J.C., Fischbach K., Pacheco G.J., Chen S.G., Obrenovich M.E., Ward W.F., Richardson A.G., Smith M.A., Gasimov E., Perry G., Ames B.N
The advent of omics technologies has enabled researchers to explore tinnitus in greater detail using these advanced techniques 17,18